Most profitable healthcare companies — page 2

Ranks 101–184 of 184 · Fiscal year 2025 · Data as of September 25, 2026

Net income
#CompanyNet incomeYoY15-year trend
101OrganonOGNUS$187M−78.4%
102PenumbraPENUS$178M+1,168.1%
103Concentra Group Holdings ParentCONUS$166M−0.1%
104Pediatrix MedicalMDUS$165M+$264M
105CormedixCRMDUS$163M+$181M
106Nu Skin EnterprisesNUSUS$160M+$307M
107Harmony BiosciencesHRMYUS$159M+9.1%
108Stevanato GroupSTVNIT$158M+24.0%
109Bausch Health CompaniesBHCCA$157M+$203M
110Adma BiologicsADMAUS$147M−25.7%
111Inspire Medical SystemsINSPUS$145M+171.8%
112Ardent HealthARDTUS$136M−35.4%
113Merit Medical SystemsMMSIUS$128M+6.8%
114Hims & Hers HealthHIMSUS$128M+1.8%
115Ligand PharmaceuticalsLGNDUS$124M+$128M
116National HealthcareNHCUS$120M+17.7%
117Integer HoldingsITGRUS$103M−14.3%
118Corcept TherapeuticsCORTUS$99.7M−29.4%
119Amphastar PharmaceuticalsAMPHUS$98.1M−38.5%
120Addus HomecareADUSUS$95.9M+30.3%
121EmbectaEMBCUS$95.4M+21.8%
122InmodeINMDIL$93.8M−48.2%
123Keros TherapeuticsKROSUS$87.0M+$274M
124CryoportCYRXUS$78.3M+$193M
125Ani PharmaceuticalsANIPUS$78.0M+$97.0M
126Sotera HealthSHCUS$77.9M+75.6%
127Bio-TechneTECHUS$73.4M−56.3%
128Amneal PharmaceuticalsAMRXUS$72.1M+$189M
129Ufp TechnologiesUFPTUS$68.3M+15.8%
130VeracyteVCYTUS$66.4M+175.5%
131Collegium PharmaceuticalCOLLUS$63.0M−8.7%
132Starling OncologySTLNUS$60.6M−6.3%
133Healthcare ServicesHCSGUS$59.1M+49.6%
134Kiniksa Pharmaceuticals InternationalKNSAGB$59.0M+$102M
135ProgynyPGNYUS$58.5M+7.7%
136Lemaitre VascularLMATUS$57.7M+31.1%
137Emergent BiosolutionsEBSUS$52.6M+$243M
138SBC Medical GroupSBCUS$51.0M+9.4%
139Guardian Pharmacy ServicesGRDNUS$49.2M+$159M
140RepligenRGENUS$48.9M+$74.4M
141Mimedx GroupMDXGUS$48.6M+14.5%
142Phibro Animal HealthPAHCUS$48.3M+1,897.7%
143ConmedCNMDUS$47.1M−64.4%
144Envista HoldingsNVSTUS$47.0M+$1.2B
145Elite PharmaceuticalsELTPUS$44.9M+$49.2M
146Cadre HoldingsCDREUS$44.1M+22.2%
147Strata Critical MedicalSRTAUS$41.3M+$68.7M
148U S Physical TherapyUSPHUS$39.6M+26.0%
149Organogenesis HoldingsORGOUS$37.0M+4,011.1%
150Puma BiotechnologyPBYIUS$31.1M+2.8%
151National VisionEYEUS$29.6M+$58.1M
152Pennant GroupPNTGUS$29.6M+31.1%
153AlvotechALVOLU$27.9M+$260M
154BioteBTMDUS$27.0M+756.7%
155Ironwood PharmaceuticalsIRWDUS$24.0M+2,629.5%
156Privia HealthPRVAUS$22.9M+59.3%
157InogenINGNUS$22.7M−36.6%
158BioventusBVSUS$22.7M+$58.9M
159KamadaKMDAIL$20.2M+39.7%
160Natures Sunshine ProductsNATRUS$19.5M+153.7%
161TrupanionTRUPUS$19.4M+$29.1M
162Tactile Systems TechnologyTCMDUS$19.1M+12.5%
163Niagen BioscienceNAGEUS$17.4M+103.3%
164VericelVCELUS$16.5M+59.4%
165Viemed HealthcareVMDUS$15.4M+35.1%
166NRC HealthNRCUS$11.6M−53.2%
167Usana Health SciencesUSNAUS$10.8M−74.4%
168LifevantageLFVNUS$9.8M+233.8%
169ArtivionAORTUS$9.8M+$23.1M
170Lifestance HealthLFSTUS$9.7M+$67.1M
171TalkspaceTALKUS$7.8M+578.8%
172BilliontooneBLLNUS$7.5M+$49.0M
173Pacira BiosciencesPCRXUS$7.0M+$107M
174Infusystem HoldingsINFUUS$6.6M+182.6%
175MannkindMNKDUS$5.9M−78.7%
176Pharming GroupPHARNL$2.9M+$14.7M
177Warby ParkerWRBYUS$1.6M+$22.0M
178Icu MedicalICUIUS$732,000+$118M
179Xeris BiopharmaXERSUS$554,000+$55.4M
180ChemedCHEUS$265,238−12.2%
181Aveanna HealthcareAVAHUS$225,034+$235,963
182HaemoneticsHAEUS$97,308−42.0%
183VaxartVXRTUS$16,327+$83,275
184Xtant MedicalXTNTUS$4,973+$21,422

All figures from SEC filings · FY2025 · 84

see sources

Download this data as a CSV →

Most profitable companies →

By sector

By country